Mitsubishi Chemical Group. Science. Value. Life.
Explore Our Treatments

Media

News

Important news about our latest
developments in science & medicine.

See All
 
Apr 15, 2024
Mitsubishi Tanabe Pharma America to Present Healthcare Resource Utilization Data in RADICAVA ORS® (edaravone)-Treated ALS Patients at AMCP 2024 Read More
 
Apr 12, 2024
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting Read More
 
Apr 08, 2024
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) Read More
Company Statement
Mar 19, 2024
First Patient Enrolled in MTPA INSPIRE Study of Investigational Dersimelagon for EPP and XLP Read More
 
Mar 18, 2024
Mitsubishi Tanabe Pharma America Announces Publication of Positive Results from Phase 3 BouNDless Trial of Investigational ND0612 in People with Parkinson’s Disease Experiencing Motor Fluctuations Read More
 
Mar 04, 2024
Mitsubishi Tanabe Pharma America Announces Presentations in Parkinson’s Disease at 2024 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) Read More

Media Assets

Company fact sheets and additional details.

Download press kit
RADICAVA ORS® (edaravone)
Download All Fact Sheets
Frequently Asked Questions Science and Perseverance Road to FDA Approval How Is It Used?
Fact Sheet
Download All Fact Sheets
RADICAVA® (edaravone)
Download All Fact Sheets
Frequently Asked Questions Science and Perseverance Road to FDA Approval How Is It Used?
Fact Sheet B-Roll Supply Infographic
Download All Fact Sheets
EXSERVAN® (riluzole) Oral Film
Download All Fact Sheets
Access Fact Sheets B-Roll
Download All Fact Sheets
Mitsubishi Tanabe
Pharma America, Inc.
Corporate Fact Sheet
Media Inquiries
Media_MTPA@mt-pharma-us.com
You are leaving this website, hosted by Mitsubishi Tanabe Pharma America, Inc.
This link will take you to a website to which our Privacy Policy and Terms of Use does not apply. Mitsubishi Tanabe Pharma America, Inc. does not control the content of this third-party site.
Continue
Cancel